Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

NCT05028361 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

348

Enrollment

OTHER

Sponsor class

Conditions

Quality of Life
Injection Site Reaction
Adverse Drug Event
Systemic Reaction

Interventions

BIOLOGICAL: mRNA COVID-19
BIOLOGICAL: IIV4
OTHER: Placebo (saline)

Sponsor

Duke University

Collaborators

[object Object]
[object Object]
[object Object]